$21.8 M

OGEN Mkt cap, 10-Jun-2019
Oragenics Net income (Q2, 2019)-4.8 M
Oragenics EBIT (Q2, 2019)-4.9 M
Oragenics Cash, 30-Jun-201925.7 M

Oragenics Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.0m939.9k1.2m

Revenue growth, %

(9%)25%(100%)

Cost of goods sold

343.4k369.6k481.7k

Gross profit

688.9k570.3k694.1k

Gross profit Margin, %

67%61%59%

R&D expense

9.4m8.8m4.8m3.5m6.0m

General and administrative expense

7.5m3.5m3.8m3.2m4.0m

Operating expense total

16.9m12.3m8.5m6.7m10.0m

EBIT

(16.2m)(5.8m)(11.7m)(10.0m)

EBIT margin, %

(1570%)(619%)(991%)

Interest expense

17.5k4.0k76.7k4.1k216.3k5.8k

Interest income

23.5k37.0k21.4k40.1k10.2k86.5k

Pre tax profit

(16.1m)(5.8m)(11.7m)(8.5m)(6.7m)(9.9m)

Income tax expense

Net Income

(16.1m)(5.8m)(11.7m)(7.0m)(6.7m)(9.9m)

Oragenics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

16.3m10.4m5.1m4.1m6.2m20.2m

Accounts Receivable

64.4k21.1k24.1m

Inventories

288.4k119.4k321.5k141.1k

Current Assets

16.8m11.0m5.6m4.2m7.2m21.9m

PP&E

26.9k109.3k140.7k87.5k21.7k116.3k

Total Assets

16.8m11.1m5.8m4.3m7.2m22.0m

Accounts Payable

910.0k710.2k969.8k1.3m818.0k1.0m

Short-term debt

Current Liabilities

992.8k796.3k1.0m1.3m898.5k1.2m

Long-term debt

Total Debt

Additional Paid-in Capital

86.0m86.2m92.3m97.6m101.4m126.1m

Retained Earnings

(70.2m)(75.9m)(87.7m)(94.7m)(101.4m)(111.4m)

Total Equity

15.8m10.3m4.7m3.0m6.3m20.9m

Financial Leverage

1.1 x1.1 x1.2 x1.5 x1.1 x1.1 x

Oragenics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(16.1m)(5.8m)(11.7m)(7.0m)(6.7m)(9.9m)

Depreciation and Amortization

76.5k27.7k71.2k75.0k65.8k30.1k

Accounts Receivable

5.4k48.8k

Inventories

203.6k214.8k66.1k229.3k

Accounts Payable

(234.5k)(199.7k)331.1k446.0k525.8k225.3k

Cash From Operating Activities

(6.8m)(5.6m)(5.1m)(7.1m)(6.4m)(9.1m)

Purchases of PP&E

(18.8k)(110.7k)(102.5k)(27.2k)(124.7k)

Cash From Investing Activities

(18.8k)(110.2k)(101.2k)(124.7k)

Cash From Financing Activities

13.1m(159.9k)8.4m23.2m

Interest Paid

3.1k4.1k5.2k4.1k4.5k5.8k

Oragenics Ratios

USDY, 2019

Financial Leverage

1.1 x